Supplementary table 1 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
收藏数据链接：
官方服务：
资源简介：
Clinical and prognostic information of ARID1A proficient and ARID1A deficient colorectal cancer patients receiving immune checkpoint inhibitors, bevacizumab or cetuximab therapy
创建时间：
2025-03-03
